ArticleF1000Research2025
Prevalence of benzodiazepines prescription in the dental office across the Eastern region of Saudi Arabia.
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anesthesia and sedation services for dental outpatients are commonly indicated for the management of fear, anxiety, and phobia, usually with children and patients with some medical conditions. To date, there has been no information on the prevalence of oral sedatives (Benzodiazepines, OBZ) used for dental patients in the Eastern region of Saudi Arabia. Hence, this study aimed to determine the prevalence of oral sedatives used for dental patients in the Eastern region of the Kingdom of Saudi Arabia. Material and Methods: An electronic survey (though Google forms) was sent to the practitioners in the Eastern region of Saudi Arabia via e-mail/social media. The calculated representative sample size required for the study was 327. All participants were registered with the Saudi Commission for Health Specialties (SCFHS). The questionnaire consisted of 28 questions, which included demographics and oral benzodiazepine prescription patterns. Data obtained were analyzed using the SPSS (Version 23.0) software. Results: The completed response was received from 378 dentists who participated in the study. We found that 6.9% (n=26) had prescribed oral benzodiazepines to adult patients for anxiety management (as oral pre-medication or conscious sedation). Specialty dentists/trainees, private sector dentists, and non-Kingdom of Saudi Arabia (KSA), foreign trained/qualified dentists had prescribed more OBZs. A statistically significant association was found between barriers to prescribing for managing anxious patients and the type of dentist (p<.05). Conclusion: This cross-sectional study concluded that the prevalence of prescribing OBZ in the Eastern region of Saudi Arabia is low. The most important barriers identified were the lack of training and formal qualifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.